4//SEC Filing
Urbach Tanya Durkee 4
Accession 0001104659-22-098628
CIK 0001175680other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 9:48 PM ET
Size
8.4 KB
Accession
0001104659-22-098628
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Urbach Tanya Durkee
Director
Transactions
- Award
Non-qualified stock option (right to buy)
2022-09-06+112,500→ 112,500 totalExercise: $0.50From: 2022-09-06Exp: 2032-09-06→ Common Stock (112,500 underlying) - Award
Non-qualified stock option (right to buy)
2022-09-06+247,111→ 241,111 totalExercise: $0.50Exp: 2032-09-06→ Common Stock (247,111 underlying)
Holdings
- 162,113
Common Stock
Footnotes (1)
- [F1]As of August 31, 2022, 61,777 shares have vested; the balance will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.
Documents
Issuer
CytoDyn Inc.
CIK 0001175680
Entity typeother
Related Parties
1- filerCIK 0001897672
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 9:48 PM ET
- Size
- 8.4 KB